• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

Symposium: 57th American Society of Tropical Medicine and Hygiene (ASTMH)

7-11 December 2008

New Orleans, USA

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

DNDi sponsored a HAT Symposium: “Addressing R&D challenges in making new drugs available for HAT: potential in the pipeline and recent clinical results”, including presentations on HAT platform, NECT, fexinidazole, and DB289.

DNDi also co-chaired a Malaria Symposium with sanofi-aventis.

Agenda

  • If you would like to download the full HAT Symposium with the HAT Platform’s full Agenda, please click here.
  • Malaria Symposium with sanofi-aventis

DNDi co-chaired a sanofi-aventis Symposium on “From field experience to the discovery of anti malarials: partnerships
in action” where the ASAQ field monitoring plan was presented.

  • Chair: Wilfred Mbacham, Biotechnologies Centre, University of Yaounde I, Yaounde, Cameroon.

1 Review of clinical experience with the artesunate-amodiaquine fixed-dose combination
by Milijaona Randrianarivelojosia
Institut Pasteur, Madagascar.

2 Efficacy and safety monitoring in the field: The artesunate-amodiaquine fixed-dose combination monitoring plan
by Francois Bompart
sanofi-aventis Access to Medicines, Paris, France.

3 New approaches for the treatment of severe malaria: bis-thiazolium SAR97276
by Henri Vial
University Montpellier, Montpellier, France.

4 The search for new antimalarial drugs: Sanofi- Aventis’ R and D program
by Laurent Fraisse
sanofi-aventis, Toulouse, France.

Presentations

  • HAT Symposium with the HAT Platform
  • Chairs: Leon Kazumba, HAT Platform, Kinshasa, DRC, & Pere Simarro, WHO, Geneva, Switzerland

1 HAT Platform – Success to date, and challenges/opportunities ahead in overcoming difficulties in clinical research of HAT
drugs & in developing regional research platform
by Fred Kansiime, HAT Platform, Coordination Office for Control of Trypanosomiasis in Uganda, Kampala, Uganda
.

2 Phase III results of multi-center study evaluating nifurtimox-eflorthine combination for treatment (NECT) of Stage 2 HAT
by Elisabeth Baudin, on behalf of Gerardo Priotto, Epicentre, Paris, France
.

3 Research results evaluating the diamidine class for the treatment of HAT
by Carol Olson, Immtech Pharmaceuticals, Vernon Hills, IL, USA.

4 Fexinidazole: a rediscovered nitroimidazole drug candidate moving into clinical development for HAT
by Els Torreele, Drugs for Neglected Diseases initiative, Geneva, Switzerland
.

Interventions by Christian Burri, Swiss Tropical Institute, Basel, Switzerland, and Constantin Miaka Mia Bilenge, HAT National Control Program, Kinshasa, Democratic Republic of the Congo (DRC), followed by a Q&A session.

  • Malaria Symposium with sanofi-aventis
  • Chair: Wilfred Mbacham, Biotechnologies Centre, University of Yaounde I, Yaounde, Cameroon.

1 Review of clinical experience with the artesunate-amodiaquine fixed-dose combination
by Milijaona Randrianarivelojosia
Institut Pasteur, Madagascar, Madagascar.

2 Efficacy and safety monitoring in the field: The artesunate-amodiaquine fixed-dose combination monitoring plan
by Francois Bompart
sanofi-aventis Access to Medicines, Paris, France.

3 New approaches for the treatment of severe malaria: bis-thiazolium SAR97276
by Henri Vial
University Montpellier, Montpellier, France.

4 The search for new antimalarial drugs: Sanofi- Aventis’ R and D program
by Laurent Fraisse
sanofi-aventis, Toulouse, France.

  • Additional partner presentations

DNDi was also pleased to have a number of other presentations made by project partners. These included the following:

– ASMQ intervention study
– ASMQ age- and weight-based dosing
– Anacor
– Scynexis

Press Releases

  • If you would like to read the HAT Symposium with the HAT Platform’s Press Release, please click here.

Science.com Article

  • If you would like to read the Science.com’s Press Article, please click here.

Videos

DNDi facilitated 3 Video sessions on “Survival – the Deadliest Diseases”

  • If you would like to see the 57th ASMTH’s flyer, please click here.

Other events

Loading...
22 May 2023, 5:45 PM

Geneva, Switzerland

Strengthening UHC through innovative & inclusive tools

8-12 May 2023

Lisbon, Portugal and online

ESPID 2023

13 April 2023, 2 PM London

London, United Kingdom

Ending the neglect of Chagas disease in the UK

11-12 April 2023

Barcelona, Spain and online

XVIII Jornadas sobre la enfermedad de Chagas

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo